Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.


PURPOSE We aimed to compare the clinical efficacy and ocular surface variables of olopatadine, ketotifen fumarate, epinastine, emedastine and fluorometholone acetate ophthalmic solutions in preventing the signs and symptoms of seasonal allergic conjunctivitis (SAC). METHODS This was a prospective, randomized, double-blinded and placebo-controlled study. A… (More)
DOI: 10.1111/j.1755-3768.2008.01265.x

2 Figures and Tables


  • Presentations referencing similar topics